AML patients receiving vitamin C/D supplements found to have fewer complications, but no overall survival benefit

Patients with acute myeloid leukemia (AML) who received vitamin C and D supplements while undergoing intensive chemotherapy had lower rates of complications, such as infections, bleeding, and inflammation, when compared with similar, previously treated patients who did not receive these supplements.

Leave A Comment

Your email address will not be published. Required fields are marked *